Consolidated Statements of Income - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Statement [Abstract]
Revenue	$ 4,643	$ 3,817	$ 13,512	$ 10,385
Cost of revenue (COR)	1,491	1,364	4,486	3,762
Gross profit	3,152	2,453	9,026	6,623
Research and development (R&D)	388	386	1,165	1,142
Selling, general and administrative (SG&A)	412	407	1,262	1,225
Acquisition charges	47	51	142	151
Restructuring charges/other	0	0	0	24
Operating profit	2,305	1,609	6,457	4,081
Other income (expense), net (OI&E)	15	27	134	151
Interest and debt expense	45	49	135	142
Income before income taxes	2,275	1,587	6,456	4,090
Provision for income taxes	328	234	825	183
Net income	$ 1,947	$ 1,353	$ 5,631	$ 3,907
Earnings per common share (EPS):
Basic (in dollars per share)	$ 2.10	$ 1.47	$ 6.08	$ 4.22
Diluted (in dollars per share)	$ 2.07	$ 1.45	$ 5.99	$ 4.17
Average shares outstanding (millions):
Basic (in shares)	923	917	923	921
Diluted (in shares)	936	929	936	933
Diluted EPS:
Net income	$ 1,947	$ 1,353	$ 5,631	$ 3,907
Income allocated to RSUs	(9)	(6)	(24)	(19)
Income allocated to common stock for diluted EPS	$ 1,938	$ 1,347	$ 5,607	$ 3,888